К основному контенту

"Your neighborhood shouldn't influence your odds of seeing your grandchildren grow up,"

"Your neighborhood shouldn't influence your odds of seeing your grandchildren grow up," said lead researcher Dr. Marc Gourevitch, chairman of the department of population health at NYU Langone Health System.
His colleague, co-author Benjamin Spoer, said researchers have known for a while that conditions from neighborhood to neighborhood can have "profound influence" on how long and how well people live.
"But we were surprised to see just how large the gap in life expectancy can be between neighborhoods, and how strong the link was between life expectancy and segregation, across all different kinds and sizes of cities," Spoer said in an NYU news release.
Chicago had the biggest gap in life expectancy between neighborhoods at 30.1 years. That was followed by Washington, D.C., at 27.5 years; New York City, 27.4; and New Orleans and Buffalo, N.Y., both at 25.8 years.
Scores on measures of racial and ethnic segregation in these cities were more than double the average for all 500 cities studied, the researchers found.
In New York City, for example, people living in East Harlem have an average life expectancy of 71.2 years. A few blocks away, on the affluent Upper East Side, people live to 89.9.
The nation's lowest life expectancy gap was found just outside Indianapolis, in Fishers, Ind., a city of 92,000. Its gap was 2.4 years across neighborhoods.
Others with the smallest gaps were Cicero, Ill (4.5 years); Lynwood, Calif. (4.8); Livermore, Calif. (5.1) and Meridian, Idaho (5.3). These cities were also the least segregated, researchers said.
"Each city has its own history and challenges that influence how long its residents live," Gourevitch said in the news release. "The data on life expectancy gaps are an invitation for city leaders to dig deeper into the conditions that influence health, to better target action to close these gaps, and ultimately to improve health for everyone."
The investigators said these efforts can be focused on addressing systemic segregation, adding affordable housing and improving air quality.

Комментарии

Популярные сообщения из этого блога

A natural treatment for ED?

Erectile dysfunction — the inability to get and keep an erection firm enough for sex — is a common problem. You've likely seen advertisements for erectile dysfunction herbs or supplements to "increase your sexual performance." Could they work for you? Erectile dysfunction supplements and other natural remedies have long been used in Chinese, African and other cultures. But unlike prescription medications for erectile dysfunction, such as sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis, Adcirca) and avanafil (Stendra), erectile dysfunction herbs and supplements haven't been well-studied or tested. Some can cause side effects or interact with other medications. And the amount of the active ingredient can vary greatly from product to product. Here's a guide to erectile dysfunction herbs and supplements: DHEA Some evidence shows that dehydroepiandrosterone (DHEA) increases libido in women and helps erectile dysfunction in men. DHEA app...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...